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Background: Mean platelet volume (MPV), a marker of platelet activity determined on routine hemogram, is associated with adverse 
cardiovascular events. The relationship between MPV and long-term survival in patients undergoing coronary revascularization is unknown. 
Methods: We evaluated 1534 patients who underwent PCI from 1993 to 2005 and 1138 patients who underwent CABG from 1995 to 2005 at 
the Manhattan VA hospital. MPV and platelet count were collected at time of procedure, and, in patients who underwent PCI, additional data were 
collected at 30 days, 60 days, 90 days, 1 year, 2 years, and 3 years post-PCI. Survival was determined by query of the social security death index. 
Multivariate Cox Proportional Hazards model was used to examine risk due to demographic and clinical variables, as well as their interaction, on 
survival. To investigate the role of change in MPV values we estimated speed of change in MPV using a linear regression model and evaluated the 
effect of the estimated speed of change on long-term survival using logistic model.
Results: Overall mortality on follow-up was 49.7% and 46.1% (mean follow-up 7.9 and 7.1 years) post-PCI and CABG, respectively. We found a 
significant effect of interaction between baseline MPV and platelet count on survival in patients undergoing PCI (p=0.04) and CABG (p=0.03). In 
patients undergoing CABG, baseline MPV value above the median (8.7 femtoliter) were associated with lower long-term survival (HR=0.84, p=0.04). 
Additional analysis demonstrated that, in patients undergoing PCI, a statistically significant increase in MPV over time post-PCI was associated with a 
higher risk of mortality (OR=3.6, p=0.03).
Conclusions: Preprocedural MPV correlates independently with poor long-term survival following PCI and CABG. Furthermore, the risk of mortality 
following PCI increases in patients whose MPV increases over time. Monitoring MPV after coronary revascularization may play a role in risk 
stratification.
